Indivior Pharmaceuticals, Inc.

INDVNasdaq· Pharmaceutical Preparations

Price History

Revenue

$1.2B

▲ 4.3% YoY

Net Income

$210.0M

▲ 2900.0% YoY

EPS

$1.64

▲ 3180.0% YoY

Cash

$195.0M

▼ 38.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.